Samples #15399 and #15400 were submitted together. Sample #15399 is a soft white powder (pictured above), and sample #15400 is a purplish crystalline powder.
Two submission forms were submitted with these samples, one for material sold as MDMA and described as ''white powder/crystals blue tint'', and the other one for material sold as 2C-B and described as ''white powder''.
The submission form for the material sold as MDMA and described as ''white powder/crystals blue tint'' accompanied the soft white powder. The material sold as 2C-B and described as ''white powder'' accompanied the purplish/brownish crystalline powder.
Because of the actual content of these two powders -- GC/MS showed the soft white powder to be 2C-B, and the purplish crystalline powder to be MDMA -- it is the DrugsData crew's belief that each submission form arrived at the lab accompanying the wrong powder, that they effectively arrived switched.
We've confirmed the sample of soft white powder pictured above is 2C-B. If you sent in these two samples, the descriptions of the physical characteristics of the powders might reassure you that the submission forms were switched. Or, you can reagent-test them to distinguish the MDMA from the 2C-B to be double sure.
*tl;dr This white powder, confirmed to be 2C-B arrived at the lab with a submission form for a sample sold as MDMA.*
Contact info (at) drugsdata (dot) org about samples #15399 and #15400 if you have any questions.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
Two submission forms were submitted with these samples, one for material sold as MDMA and described as ''white powder/crystals blue tint'', and the other one for material sold as 2C-B and described as ''white powder''.
The submission form for the material sold as MDMA and described as ''white powder/crystals blue tint'' accompanied the soft white powder. The material sold as 2C-B and described as ''white powder'' accompanied the purplish/brownish crystalline powder.
Because of the actual content of these two powders -- GC/MS showed the soft white powder to be 2C-B, and the purplish crystalline powder to be MDMA -- it is the DrugsData crew's belief that each submission form arrived at the lab accompanying the wrong powder, that they effectively arrived switched.
We've confirmed the sample of soft white powder pictured above is 2C-B. If you sent in these two samples, the descriptions of the physical characteristics of the powders might reassure you that the submission forms were switched. Or, you can reagent-test them to distinguish the MDMA from the 2C-B to be double sure.
*tl;dr This white powder, confirmed to be 2C-B arrived at the lab with a submission form for a sample sold as MDMA.*
Contact info (at) drugsdata (dot) org about samples #15399 and #15400 if you have any questions.